Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 7Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 24Active not recruiting 10Terminated 8Withdrawn 7Recruiting 5Not yet recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other neoplasm 1Other 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Recurrence 2Prostatic Neoplasms 2Sezary Syndrome 1Neoplasm Metastasis 1Mycosis Fungoides 1Malignant Neoplasms of Female Genital Organs 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Glioblastoma 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × Surveys and Questionnaires × Clear all
NCT03628144 2020-09-10

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03128281 2019-05-30

Pneumoperitoneum Management With Low vs. Higher Pressure

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Other neoplasm

Malignant Neoplasms of Female Genital Organs

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
CNS

Glioblastoma, Recurrence

NCT02645591 2016-11-22

Randomized AmnioFix Study During Radical Prostatectomy

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02420587 2015-04-20

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT01518140 2013-08-13

BiPAP-Vapotherm RCT

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Other

Dyspnea, Neoplasm Metastasis, Recurrence

NCT00969085 2012-09-07

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

M.D. Anderson Cancer Center

Phase 2 Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡